C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.75 AUD
Market Closed
Updated:
Apr 28, 2024
Section:
Relative Value
The Relative Value of one CYC stock under the Base Case scenario is 3.59 AUD. Compared to the current market price of 1.75 AUD, Cyclopharm Ltd is Undervalued by 51%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CYC
Relative Value
Base Case
3.59
AUD
Undervaluation 51%
C
Valuation Multiples
Multiples Across Competitors
CYC Competitors Multiples
Cyclopharm Ltd Competitors
Cyclopharm Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
C
|
Cyclopharm Ltd
ASX:CYC
|
164.7m AUD | 5.9 | -35 | -18.3 | -18.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.7 | 38.9 | 18.6 | 31.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 10.2 | 30.8 | 26.7 | 26.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
